Skadden is representing Greenhill Capital Partners, L.L.C. as financial advisor to Roche Holding Ltd. (Switzerland) in an unsolicited approximately $42 billion bid via a tender offer for the remaining shares of Genentech, Inc. that Roche did not already own. Both Roche and Genentech are pharmaceutical companies.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates